Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids

Alamar Biosciences, Inc. Israel Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen California

View original content:https://www.prnewswire.co.uk/news-releases/alamar-biosciences-announces-commercial-launch-of-the-argo-ht-system-and-the-nulisaseq-inflammation-panel-250-for-ultra-high-sensitivity-protein-analysis-in-biofluids-302026156.html